Unfortunately, it’s a compounding problem that’s discouraging aspiring medical school students and pediatric residents from ...

(Plexium), a leading next-generation targeted protein degradation company, today announced that initial Phase 1 clinical results with PLX-4545, a selective IKZF2 molecular glue degrader, and ...

Wednesday, several parents who know what that pain feels like were at the Indiana Statehouse to tell lawmakers about losing ...

Raj Nooyi Endowed Research Award Fund supports studies on improving care for children with complex needs and advancing ...

“Low vaccination rates and a lack of visible support from public health leadership can undermine public trust in vaccines, ...